Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

Published:2012-02 Issue:2 Volume:52 Page:243-250
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Stangier Joachim,Stähle Hildegard,Rathgen Karin,Roth Willy,Reseski Kathrin,Körnicke Thomas

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010393342/fullpdf

Reference21 articles.

1. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial;Eriksson;J Thromb Haemost,2005

2. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial;Eriksson;J Thromb Haemost,2007

3. Dabigatran etexilate versus enoxaparin for the prevention of venous thromboembolism after total hip replacement: a randomized, double-blind, non-inferiority trial;Eriksson;Lancet,2007

4. Safety and efficacy of a new oral direct thrombin inhibitor dabigatran in atrial fibrillation: a dose finding trial with comparison to warfarin;Wallentin;Eur Heart J,2005

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach;Clinical Pharmacology in Drug Development;2024-05-16

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

4. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice;Pharmaceutics;2022-05-24

5. The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects;Pharmacogenomics and Personalized Medicine;2021-04